We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+1.68%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$145M
AUM Growth
+$490K
Cap. Flow
-$1.18M
Cap. Flow %
-0.82%
Top 10 Hldgs %
31.19%
Holding
139
New
6
Increased
39
Reduced
73
Closed
2

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$1.85M
2
PX
Praxair Inc
PX
+$1.04M
3
GILD icon
Gilead Sciences
GILD
+$461K
4
BIDU icon
Baidu
BIDU
+$402K
5
TECH icon
Bio-Techne
TECH
+$358K

Sector Composition

Rank Sector Weight
1 Healthcare 23.4%
2 Technology 12.69%
3 Financials 11.68%
4 Industrials 8.87%
5 Energy 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETR icon
26
Entergy
ETR
$50.5B
$1.68M 1.16%
50,130
+450
+0.9% +$14.2K
LLL
27
DELISTED
L3 Technologies, Inc.
LLL
$1.56M 1.08%
13,191
-255
-2% -$28.5K
GE icon
28
GE Aerospace
GE
$368B
$1.54M 1.06%
12,428
-237
-2% -$29.3K
MTB icon
29
M&T Bank
MTB
$35.8B
$1.53M 1.05%
12,587
-145
-1% -$16.7K
TEVA icon
30
Teva Pharmaceuticals
TEVA
$40.4B
$1.52M 1.05%
28,750
-1,600
-5% -$73.9K
ABT icon
31
Abbott
ABT
$181B
$1.49M 1.03%
38,789
-445
-1% -$17.2K
NVS icon
32
Novartis
NVS
$295B
$1.49M 1.03%
19,530
-1,841
-9% -$134K
EXPD icon
33
Expeditors International
EXPD
$21.9B
$1.44M 0.99%
36,207
+550
+2% +$22.6K
TECH icon
34
Bio-Techne
TECH
$11.2B
$1.38M 0.95%
64,640
-15,892
-20% -$358K
BRK.A icon
35
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.31M 0.91%
7
SPY icon
36
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$1.23M 0.85%
6,600
+2,399
+57% +$440K
VZ icon
37
Verizon
VZ
$193B
$1.22M 0.84%
+25,692
New +$1.21M
NXGN
38
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1.18M 0.82%
70,150
+2,800
+4% +$50.8K
PAYX icon
39
Paychex
PAYX
$41.3B
$1.15M 0.79%
26,873
-7,410
-22% -$314K
WMT icon
40
Walmart Inc
WMT
$888B
$1.04M 0.72%
40,926
-375
-0.9% -$9.42K
BDX icon
41
Becton Dickinson
BDX
$44.9B
$1.03M 0.71%
9,060
-333
-4% -$36.6K
AMGN icon
42
Amgen
AMGN
$205B
$1.03M 0.71%
8,348
-127
-1% -$15.4K
CME icon
43
CME Group
CME
$96.8B
$1.02M 0.71%
13,815
-1,105
-7% -$83.4K
APA icon
44
APA Corp
APA
$12.8B
$997K 0.69%
12,024
+725
+6% +$59.5K
DGX icon
45
Quest Diagnostics
DGX
$25.8B
$973K 0.67%
16,796
+1,805
+12% +$96.7K
NSC icon
46
Norfolk Southern
NSC
$74.9B
$960K 0.66%
9,875
-50
-0.5% -$4.64K
CHRW icon
47
C.H. Robinson
CHRW
$17.4B
$952K 0.66%
18,165
+5,775
+47% +$314K
CHL
48
DELISTED
China Mobile Limited
CHL
$919K 0.63%
+20,150
New +$957K
DCM
49
DELISTED
NTT DOCOMO, Inc.
DCM
$896K 0.62%
56,800
-50
-0.1% -$806
BIDU icon
50
Baidu
BIDU
$36.7B
$892K 0.62%
5,855
-2,405
-29% -$402K

Similar funds

Roberts, Glore & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Roberts, Glore & Co held 139 positions worth $145M, up 0.34% from $144M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Roberts, Glore & Co's Q1 2014 filing shows 6 new, 39 increased, 73 reduced and 2 closed positions. Its largest new stake was Verizon: 25,692 shares worth $1.22M. The largest sale was Vodafone, an estimated $1.85M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q1 2014 buy was Verizon: 25,692 shares worth $1.22M.
  • Roberts, Glore & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2014, an estimated $440K increase.
  • Roberts, Glore & Co's biggest Q1 2014 reduction was Vodafone, cutting an estimated $1.85M.
  • Roberts, Glore & Co fully exited Praxair Inc in Q1 2014, selling an estimated $1.04M.
  • Roberts, Glore & Co's ten largest holdings make up 31% of its $145M portfolio in Q1 2014.
  • Roberts, Glore & Co opened 6 new positions and closed 2 in Q1 2014.
  • Roberts, Glore & Co's portfolio value rose 0.34% quarter-over-quarter to $145M.

Based on Roberts, Glore & Co's 13F filing for Q1 2014, filed 7 May 2014.